{"organizations": [], "uuid": "7b2161b06353404083aac61cf013658ca55a3fd2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180503.html", "section_title": "Archive News &amp; Video for Thursday, 03 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-healthineers-ceo-says-keeping-eye/brief-healthineers-ceo-says-keeping-eye-out-but-in-no-hurry-for-ma-idUSL8N1SA1PD", "country": "US", "domain_rank": 408, "title": "Healthineers CEO says keeping eye out but in no hurry for M&A", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-03T15:04:00.000+03:00", "replies_count": 0, "uuid": "7b2161b06353404083aac61cf013658ca55a3fd2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-healthineers-ceo-says-keeping-eye/brief-healthineers-ceo-says-keeping-eye-out-but-in-no-hurry-for-ma-idUSL8N1SA1PD", "ord_in_thread": 0, "title": "Healthineers CEO says keeping eye out but in no hurry for M&A", "locations": [], "entities": {"persons": [], "locations": [{"name": "china", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "siemens healthineers ag", "sentiment": "negative"}, {"name": "siemens", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "atellica", "sentiment": "none"}, {"name": "berlin newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 3 (Reuters) - Siemens Healthineers AG:\n* SIEMENS HEALTHINEERS CFO SAYS EXPECT GREATEST NEGATIVE IMPACT FROM CURRENCIES IN Q3\n* HEALTHINEERS CEO SAYS WON MARKET SHARE IN MEDICAL IMAGING IN THE U.S IN Q2\n* HEALTHINEERS CEO SAYS WE ARE VERY HAPPY WITH OUR CURRENT PORTFOLIO, WE DONâ€™T SEE PROBLEMATIC GAPS\n* HEALTHINEERS CEO SAYS WE CAN MAKE TARGETED ACQUISTIONS, LOOKING IN MOLECULAR DIAGNOSTICS, ADVANCED THERAPIES\n* HEALTHINEERS CEO SAYS ALSO LOOKING IN AREA OF DIGITAL, AI\n* HEALTHINEERS CEO SAYS WILL APPROACH ANY POSSIBLE TARGETS CAUTIOUSLY, NOT IN ANY HURRY\n* HEALTHINEERS CEO SAYS EVERY ADDITIONAL TARIFF IS PROBLEMATIC WHEN ASKED ABOUT US-CHINA TRADE TENSIONS\n* HEALTHINEERS CE0 SAYS STILL NEED APPROVAL FOR ATELLICA IN CHINA AND JAPAN\n* HEALTHINEERS CFO SAYS 2017/2018 SALES MAY BE BETWEEN 200 AND 400 MILLION EUROS LOWER THAN PREVIOUS YEAR Source text for Eikon: (Reporting By Berlin Newsroom)\nOur ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-03T15:04:00.000+03:00", "crawled": "2018-05-04T16:33:05.007+03:00", "highlightTitle": ""}